To include your compound in the COVID-19 Resource Center, submit it here.

Trabectedin regulatory update

The Scottish Medicines Consortium recommended against the use of Yondelis trabectedin from PharmaMar on the National Health Service (NHS)

Read the full 196 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE